用神经肌肉阻断剂Rocuronium恶意中毒一只狗: 一个病例报告与死后量化
John P Buchweitz1,2, Justin A Zyskowski1, Kevin Cajigas3
1Michigan State University Veterinary Diagnostic Laboratory, Michigan State University College of Veterinary Medicine, 4125 Beaumont Rd, Lansing, MI, 48910, USA.
Journal of analytical toxicology
|January 9, 2026
概括
本案例报告详细介绍了第一例已知的恶意化中毒犬的案例. 毒理学分析证实了致命的罗库水平,突出了临床环境之外的非分极神经肌肉阻断剂的危险性.
科学领域:
- 兽医法医学 兽医法医学
- 毒理学 毒理学 毒理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 甲是人类麻醉中广泛使用的非去极化神经肌肉阻断剂 (NMBA).
- 它的治疗应用已在人类和实验模型中建立在狗身上.
- 本报告介绍了首个有记录的狗狗故意,致命的罗库酸中毒病例.
研究的目的:
- 为了记录第一个报告的恶意使用rocuronium化物在狗中的案例.
- 详细说明死后发现和毒理学确认的罗库.
- 强调与在非临床环境中滥用NMBA相关的风险.
主要方法:
- 案例描述:一名已故的六岁雄性猎犬死亡,情况可疑.
- 尸检检查以确定潜在的注射部位和相关的出血.
- 液体染色学-并联质谱学 (LC-MS/MS) 用于组织,血液和尿液样本的毒理分析.
主要成果:
- 尸体解剖调查显示,有焦点出血,暗示注射.
- LC-MS/MS证实了在肌肉组织,心脏血液和尿液中存在罗库化物.
- 检测到的罗库的度与麻醉的人类患者的度相当.
结论:
- 这一案例代表了首个已知的致死性罗库化中毒的案例,原因是恶意给狗的药物.
- 这些发现强调了NMBAs在受控制的兽医或医疗环境之外滥用时的显著致命性.
- 强调需要在兽医法医调查中采用多学科方法.
相关概念视频
Depolarizing Blockers: Pharmocokinetics
560
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
560
Anticholinesterase Agents: Poisoning and Treatment
1.5K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.5K
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
2.7K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
2.7K
Skeletal Muscle Relaxants: Therapeutic Uses
880
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
880
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
764
All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
764


